NasdaqCM - Nasdaq Real Time Price USD
GeoVax Labs, Inc. (GOVX)
0.9276
-0.0424
(-4.37%)
At close: May 9 at 4:00:00 PM EDT
0.9501
+0.02
+(2.43%)
Pre-Market: 8:29:47 AM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 64.49k | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
SHARKEY JOHN W PH.D. Officer | Purchase at price 0.99 per share. | Direct | 5,940 | Apr 10, 2025 |
DODD DAVID A Chief Executive Officer | Purchase at price 1.08 per share. | Direct | 10,800 | Apr 1, 2025 |
REYNOLDS MARK W Chief Financial Officer | Purchase at price 1.08 per share. | Direct | 7,343 | Mar 31, 2025 |
DODD DAVID A Chief Executive Officer | Purchase at price 1.95 per share. | Direct | 15,600 | Aug 9, 2024 |
DODD DAVID A Chief Executive Officer | Purchase at price 2.15 - 2.27 per share. | Direct | 19,781 | Feb 22, 2024 |
REYNOLDS MARK W Chief Financial Officer | Purchase at price 2.77 per share. | Direct | 5,540 | Feb 7, 2024 |
MCKEE KELLY T JR. Officer | Purchase at price 0.36 per share. | Direct | 2,500 | Dec 22, 2023 |
MCKEE KELLY T JR. Officer | Purchase at price 0.52 per share. | Direct | 5,020 | Sep 25, 2023 |
DODD DAVID A Chief Executive Officer | Purchase at price 0.57 per share. | Direct | 20,000 | Aug 25, 2023 |
REYNOLDS MARK W Chief Financial Officer | Purchase at price 0.52 per share. | Direct | 5,179 | Aug 18, 2023 |
DODD DAVID A Chief Executive Officer | Purchase at price 0.64 per share. | Direct | 20,445 | Apr 24, 2023 |
REYNOLDS MARK W Chief Financial Officer | Purchase at price 0.63 per share. | Direct | 5,040 | Apr 20, 2023 |
CHASE RANDAL D Director | Purchase at price 1.10 per share. | Direct | 11,000 | Sep 21, 2022 |
SHARKEY JOHN W PH.D. Officer | Purchase at price 0.82 per share. | Direct | 820 | Jul 1, 2022 |
MCKEE KELLY T JR. Officer | Purchase at price 1.12 per share. | Direct | 5,000 | Jun 27, 2022 |
CHASE RANDAL D Director | Purchase at price 1.21 per share. | Direct | 12,100 | Jun 21, 2022 |
MCKEE KELLY T JR. Officer | Purchase at price 0.72 per share. | Direct | 7,000 | May 5, 2022 |
MCKEE KELLY T JR. Officer | Purchase at price 0.71 per share. | Direct | 3,549 | May 4, 2022 |
MCNALLY ROBERT T Director | Purchase at price 5.00 per share. | Direct | 269,625 | Sep 29, 2020 |
REYNOLDS MARK W Chief Financial Officer | Purchase at price 5.00 per share. | Direct | 300,920 | Sep 29, 2020 |
CHASE RANDAL D Director | Purchase at price 5.00 per share. | Direct | 83,065 | Sep 29, 2020 |
DODD DAVID A Chief Executive Officer | Purchase at price 5.00 per share. | Direct | 409,350 | Sep 29, 2020 |
SPENCER JOHN N JR Director | Purchase at price 5.00 per share. | Direct | 105,120 | Sep 29, 2020 |
KOLLINTZAS DEAN G Director | Purchase at price 5.00 per share. | Direct | 59,935 | Sep 29, 2020 |
CHASE RANDAL D Director | Purchase at price 0.19 per share. | Direct | 1,900 | May 5, 2015 |
REYNOLDS MARK W Chief Financial Officer | Purchase at price 0.17 - 0.18 per share. | Direct | 5,215 | Apr 23, 2015 |
CHASE RANDAL D Director | Purchase at price 0.17 per share. | Direct | 5,100 | Apr 20, 2015 |
SPENCER JOHN N JR Director | Purchase at price 0.17 per share. | Direct | 3,015 | Apr 20, 2015 |
ROBINSON HARRIET L Officer and Director | Stock Gift at price 0.00 per share. | Direct | 0 | Jun 5, 2013 |
REYNOLDS MARK W Chief Financial Officer | Purchase at price 0.67 per share. | Direct | 10,050 | Jan 31, 2012 |
ANTEBI STEVEN S Director | Purchase at price 0.67 per share. | Direct | 20,100 | Jan 13, 2012 |
MCNALLY ROBERT T Chief Executive Officer | Purchase at price 0.67 per share. | Direct | 20,000 | Dec 30, 2011 |
REYNOLDS MARK W Chief Financial Officer | Purchase at price 0.67 per share. | Direct | 10,050 | Dec 30, 2011 |
DODD DAVID A Director | Purchase at price 0.67 per share. | Direct | 75,040 | Dec 30, 2011 |
SPENCER JOHN N JR Director | Purchase at price 0.67 per share. | Direct | 10,000 | Dec 30, 2011 |
ROBINSON HARRIET L Officer and Director | Purchase at price 0.91 per share. | Direct | 135,821 | Dec 30, 2011 |
KOLLINTZAS DEAN G Director | Purchase at price 0.67 per share. | Direct | 10,000 | Dec 30, 2011 |
ROBINSON HARRIET L Officer and Director | Stock Gift at price 0.00 per share. | Direct | 0 | Jun 22, 2011 |
ROBINSON HARRIET L Officer and Director | Stock Gift at price 0.00 per share. | Direct | 0 | Jan 6, 2011 |
ROBINSON HARRIET L Officer and Director | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 20, 2010 |
MCNALLY ROBERT T Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Oct 15, 2010 |
REYNOLDS MARK W Chief Financial Officer | Purchase at price 2.50 per share. | Direct | 2,500 | Jul 2, 2010 |
NEWMAN MARK J Officer | Purchase at price 3.25 - 3.32 per share. | Direct | 9,890 | Jun 11, 2010 |
MCNALLY ROBERT T Chief Executive Officer | Purchase at price 3.30 per share. | Direct | 990 | Jun 10, 2010 |
ROBINSON HARRIET L Officer and Director | Purchase at price 3.30 per share. | Direct | 9,900 | Jun 10, 2010 |
ROBINSON HARRIET L Officer and Director | Purchase at price 3.35 per share. | Direct | 7,035 | Jun 10, 2010 |
MCNALLY ROBERT T Chief Executive Officer | Purchase at price 3.30 - 3.32 per share. | Direct | 3,318 | Jun 9, 2010 |
REYNOLDS MARK W Chief Financial Officer | Purchase at price 3.29 - 3.35 per share. | Direct | 6,982 | Jun 9, 2010 |
HILDEBRAND DONALD G Director | Purchase at price 3.29 per share. | Indirect | 3,290 | Jun 9, 2010 |
MCNALLY ROBERT T Chief Executive Officer | Purchase at price 3.25 per share. | Direct | 3,250 | Jun 8, 2010 |
Related Tickers
VRAX Virax Biolabs Group Limited
1.0500
-0.94%
NNVC NanoViricides, Inc.
1.3200
-6.38%
SXTP 60 Degrees Pharmaceuticals, Inc.
2.3900
+5.75%
VXRT Vaxart, Inc.
0.4196
+3.10%
SLXN Silexion Therapeutics Corp
0.9848
-0.53%
IBIO iBio, Inc.
0.7733
-6.83%
LGVN Longeveron Inc.
1.3400
-10.07%
TVGN Tevogen Bio Holdings Inc.
1.0900
0.00%
GNPX Genprex, Inc.
0.2853
-0.56%
WINT Windtree Therapeutics, Inc.
0.8522
+0.39%